Abstract:The mechanisms mediating the activation of cardiac gene expression during pressure overload are not fully understood. We examined whether angiotensin II-induced activation of ventricular gene expression is related to blood pressure and ventricular mass or requires other factors by infusing angiotensin II in sham-operated and adrenalectomized rats. In sham-operated rats, angiotensin II (33 microg/kg x h, sc) produced a significant increase in mean arterial pressure (measured by telemetry) within 3 h. Mean arter… Show more
“…In agreement with previous studies, 12-15 PD123319 infusion alone had no effect on MAP; moreover, it did not modify Ang II-induced increase in blood pressure ( Figure 1A), showing that AT 2 -R is not involved in the regulation of blood pressure. As described previously, the increase in MAP by Ang II was associated with a significant decrease in heart rate, 16 remaining unaffected by PD123319 ( Figure 1B). Echocardiographic measurements showed that LV ejection fraction ( Figure 1C) and LV fractional shortening ( Figure 1D) were similar in all groups, suggesting that LV function was preserved in Ang II-induced hypertension.…”
Section: Hemodynamic Parameterssupporting
confidence: 85%
“…16 Full-length rat atrial natriuretic peptide (ANP) cDNA probe (a gift from Dr Peter Davies, Queen's University, Kingston, Canada), a 390-bp rat B-type natriuretic peptide (BNP) cDNA probe, and an 18S cDNA probe were prepared as previously reported. 16 cDNA probes for rat ␣-actin and myosin isoforms were made by reverse transcription-polymerase chain reaction (RT-PCR) and ligated to dT-tailed pCR2.1 vector by use of a TA Cloning Kit (Invitrogen).…”
Section: Isolation Of Cytoplasmic Rna and Northern Blot Analysismentioning
confidence: 99%
“…16 Full-length rat atrial natriuretic peptide (ANP) cDNA probe (a gift from Dr Peter Davies, Queen's University, Kingston, Canada), a 390-bp rat B-type natriuretic peptide (BNP) cDNA probe, and an 18S cDNA probe were prepared as previously reported. 16 cDNA probes for rat ␣-actin and myosin isoforms were made by reverse transcription-polymerase chain reaction (RT-PCR) and ligated to dT-tailed pCR2.1 vector by use of a TA Cloning Kit (Invitrogen). Sequencing with ABI PRISM 310 Genetic Analyzer (Applied Biosystems) confirmed that the probes correspond to bases 2950 to 3184 of rat skeletal ␣-actin (GenBank Accession Number v01218), 289 to 447 of rat cardiac ␣-actin (x00306), 5794 to 5923 of rat -myosin heavy chain (-MHC) (x15939), and 5830 to 5921 of rat ␣-myosin heavy chain (␣-MHC) (x15938).…”
Section: Isolation Of Cytoplasmic Rna and Northern Blot Analysismentioning
confidence: 99%
“…cDNA probes were labeled, and the membranes were hybridized, washed, and quantified as previously described. 16 …”
Section: Isolation Of Cytoplasmic Rna and Northern Blot Analysismentioning
confidence: 99%
“…PD123319 has high affinity (K i Ͼ12 nmol/L) for the AT 2 -R but a low affinity (K i Ͼ100 mol/L) for the AT 1 -R. Therefore, administration of PD123319 at a dose of 1.25 mg · kg Ϫ1 · h Ϫ1 , yielding a plasma concentration of Ϸ500 nmol/L, would result in an effective AT 2 -R blockade without affecting the AT 1 -R. 15 After 12 or 72 hours of treatment, LVs were weighed, frozen in liquid nitrogen, and stored at Ϫ80°C, as described previously. 16 …”
Background-The precise function of angiotensin II type 2 receptor (AT 2 -R) in the mammalian heart in vivo is unknown.Here, we investigated the role of AT 2 -R in cardiac pressure overload. Methods and Results-Rats were infused with vehicle, angiotensin II (Ang II), PD123319 (an AT 2 -R antagonist), or the combination of Ang II and PD123319 via subcutaneously implanted osmotic minipumps for 12 or 72 hours. Ang II-induced increases in mean arterial pressure, left ventricular weight/body weight ratio, and elevation of skeletal ␣-actin and -myosin heavy chain mRNA levels were not altered by PD123319. In contrast, AT 2 -R blockade resulted in a marked increase in the gene expression of c-fos, endothelin-1, and insulin-like growth factor-1 in Ang II-induced hypertension. In parallel, Ang II-stimulated mRNA and protein expression of atrial natriuretic peptide were significantly augmented by AT 2 -R blockade. Moreover, PD123319 markedly increased the synthesis of B-type natriuretic peptide. Furthermore, the expression of vascular endothelial growth factor and fibroblast growth factor-1 was downregulated by Ang II only in the presence of AT 2 -R blockade.
Conclusions-Our
“…In agreement with previous studies, 12-15 PD123319 infusion alone had no effect on MAP; moreover, it did not modify Ang II-induced increase in blood pressure ( Figure 1A), showing that AT 2 -R is not involved in the regulation of blood pressure. As described previously, the increase in MAP by Ang II was associated with a significant decrease in heart rate, 16 remaining unaffected by PD123319 ( Figure 1B). Echocardiographic measurements showed that LV ejection fraction ( Figure 1C) and LV fractional shortening ( Figure 1D) were similar in all groups, suggesting that LV function was preserved in Ang II-induced hypertension.…”
Section: Hemodynamic Parameterssupporting
confidence: 85%
“…16 Full-length rat atrial natriuretic peptide (ANP) cDNA probe (a gift from Dr Peter Davies, Queen's University, Kingston, Canada), a 390-bp rat B-type natriuretic peptide (BNP) cDNA probe, and an 18S cDNA probe were prepared as previously reported. 16 cDNA probes for rat ␣-actin and myosin isoforms were made by reverse transcription-polymerase chain reaction (RT-PCR) and ligated to dT-tailed pCR2.1 vector by use of a TA Cloning Kit (Invitrogen).…”
Section: Isolation Of Cytoplasmic Rna and Northern Blot Analysismentioning
confidence: 99%
“…16 Full-length rat atrial natriuretic peptide (ANP) cDNA probe (a gift from Dr Peter Davies, Queen's University, Kingston, Canada), a 390-bp rat B-type natriuretic peptide (BNP) cDNA probe, and an 18S cDNA probe were prepared as previously reported. 16 cDNA probes for rat ␣-actin and myosin isoforms were made by reverse transcription-polymerase chain reaction (RT-PCR) and ligated to dT-tailed pCR2.1 vector by use of a TA Cloning Kit (Invitrogen). Sequencing with ABI PRISM 310 Genetic Analyzer (Applied Biosystems) confirmed that the probes correspond to bases 2950 to 3184 of rat skeletal ␣-actin (GenBank Accession Number v01218), 289 to 447 of rat cardiac ␣-actin (x00306), 5794 to 5923 of rat -myosin heavy chain (-MHC) (x15939), and 5830 to 5921 of rat ␣-myosin heavy chain (␣-MHC) (x15938).…”
Section: Isolation Of Cytoplasmic Rna and Northern Blot Analysismentioning
confidence: 99%
“…cDNA probes were labeled, and the membranes were hybridized, washed, and quantified as previously described. 16 …”
Section: Isolation Of Cytoplasmic Rna and Northern Blot Analysismentioning
confidence: 99%
“…PD123319 has high affinity (K i Ͼ12 nmol/L) for the AT 2 -R but a low affinity (K i Ͼ100 mol/L) for the AT 1 -R. Therefore, administration of PD123319 at a dose of 1.25 mg · kg Ϫ1 · h Ϫ1 , yielding a plasma concentration of Ϸ500 nmol/L, would result in an effective AT 2 -R blockade without affecting the AT 1 -R. 15 After 12 or 72 hours of treatment, LVs were weighed, frozen in liquid nitrogen, and stored at Ϫ80°C, as described previously. 16 …”
Background-The precise function of angiotensin II type 2 receptor (AT 2 -R) in the mammalian heart in vivo is unknown.Here, we investigated the role of AT 2 -R in cardiac pressure overload. Methods and Results-Rats were infused with vehicle, angiotensin II (Ang II), PD123319 (an AT 2 -R antagonist), or the combination of Ang II and PD123319 via subcutaneously implanted osmotic minipumps for 12 or 72 hours. Ang II-induced increases in mean arterial pressure, left ventricular weight/body weight ratio, and elevation of skeletal ␣-actin and -myosin heavy chain mRNA levels were not altered by PD123319. In contrast, AT 2 -R blockade resulted in a marked increase in the gene expression of c-fos, endothelin-1, and insulin-like growth factor-1 in Ang II-induced hypertension. In parallel, Ang II-stimulated mRNA and protein expression of atrial natriuretic peptide were significantly augmented by AT 2 -R blockade. Moreover, PD123319 markedly increased the synthesis of B-type natriuretic peptide. Furthermore, the expression of vascular endothelial growth factor and fibroblast growth factor-1 was downregulated by Ang II only in the presence of AT 2 -R blockade.
Conclusions-Our
The results obtained in the present study show that AM overexpression improves LV systolic function without altering cardiac diastolic properties in the normal heart. Moreover, AM is a potent context-dependent modulator of LV remodeling because it promotes an adaptive response in pressure overload-induced LV hypertrophy and triggers a maladaptive process in post-infarction remodeling.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.